Compare Acadia Healthcare Company Inc (ACHC) vs Bristol-Myers Squibb Co (BMY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Bristol-Myers Squibb Co — how do they compare? Acadia Healthcare Company Inc trades at $31.35 (market cap $2.90B), while Bristol-Myers Squibb Co trades at $63.63 (market cap $129.94B). The key difference: Bristol-Myers Squibb Co is far larger — about 44.8× Acadia Healthcare Company Inc's market cap, and Bristol-Myers Squibb Co pays a 3.96% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | BMY | |
|---|---|---|
Market Cap | $2.90B | $129.94B |
Sector | Health | Health |
52-Week High | $35.61 | $65.89 |
52-Week Low | $11.68 | $42.60 |
Enterprise Value | $5.29B | $163.92B |
Dividend Yield | — | 3.96% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →
